Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Indian Journal of Experimental Biology|March 15, 2003
Cell proliferation and natural killer cell activity by polyherbal formulation, Immu-21 in miceKumar V S Nemmani, G B Jena, C S Dey, et al.
Methods and Findings in Experimental and Clinical Pharmacology|August 4, 2001
Pharmacokinetic study of paclitaxel as a 3-hour infusion in an Indian population: 135 mg/m2 vs. 175 mg/m2A B Dhanikula, R Panchagnula, I Singh, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1993
Comparative pharmacokinetics and amoebicidal activity of metronidazole and satranidazole in the golden hamster, Mesocricetus auratusA Pargal, C Rao, K K Bhopale, et al.
British Journal of Pharmacology|March 1, 1997
Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic ratsR B Jones, K Dickinson, D M Anthony, et al.
Arzneimittel-Forschung|January 1, 1985
Pharmacological profile of 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go-10213), a new antiprotozoal agent, in comparison with metronidazoleJ David, R S Grewal, C L Kaul, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 15, 2005
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatmentY Ashokraj, I Singh, K J Kaur, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinationsY Ashokraj, I Singh, K J Kaur, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 1, 2004
Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro studyY Ashokraj, S Agrawal, M V S Varma, et al.
Pageof 5